News Hub | News Direct


Beverage: Coffee/Tea/Non-Alcoholic Beverage: Spirits/Beer/Wine Casino/Gaming Fashion Food/Cooking/Baking Health & Fitness Home Goods Hospitality Leisure Activities & Hobbies Parenting Pets Photography Seniors Travel & Tourism
Article thumbnail News Release

Leaders in Real Estate Weigh in on National Rent Cap Proposals

K3 Holdings

K3 Holdings, a privately held real estate investment firm with extensive holdings throughout the United States issued a statement today regarding the recent proposal by the President of the United States to implement a national cap of 5% on annual rent increases. While leaders of K3 Holdings and Alpine LA Properties commend the White House's effort to address the escalating costs of housing, leaders believe that the proposed one-size-fits-all approach falls short in addressing the complexities of housing affordability across diverse regions. "Rent control policies, like the proposed national cap, are intended to stabilize housing expenses for tenants. However, the effectiveness of such policies, especially at a national level, remains a contentious issue," said Michael Kadisha, Principal of K3 Holdings. "While rent stabilization can provide much-needed stability to tenants, the recent White House proposal overlooks the crucial ties to economic metrics and the diverse circumstances of renters and property managers." Housing markets vary significantly across the United States, and what works in one region may not be suitable for another. Existing local rent control measures reflect regional nuances but would fall short if implemented on a national scale. "In addition to relieving pressure on renters, it is essential to recognize that landlords also face increasing costs in maintaining properties," added Nathan Kadisha, Principal of K3 Holdings. "While rent controls might stabilize or reduce rent increases, they do little to address the rising operational costs landlords face, such as maintenance, utilities, insurance, and other expenses." Market dynamics heavily influence rent prices, with supply and demand playing critical roles. Policies that discourage new construction or renovations due to stringent rent caps could exacerbate housing shortages, driving rents even higher in the long run. “Effective policy making demands a balanced approach —one that prioritizes stability, fairness, and inclusivity,” Nathan Kadisha continued. “By fostering collaboration between policymakers, tenants, landlords, and other stakeholders, we can work towards building stronger communities where safe, stable, and affordable housing is accessible to all.” “As property managers, K3 Holdings stands ready to engage in constructive dialogue and collaboration towards these shared goals. Together, we can envision a future where housing insecurity is a thing of the past, and every individual and family can thrive in a home they can afford,” Michael Kadisha said. “By striving for comprehensive, locally adaptable solutions, we can pave the way towards a more equitable housing landscape for all Americans.” ### For more information or to schedule an interview with a K3 spokesperson, please contact Dan Rene at 202-329-8357 or Contact Details Dan Rene +1 202-329-8357

July 25, 2024 02:15 PM Eastern Daylight Time

Article thumbnail News Release

This Men’s Telehealth Company Has A Unique Take On Telehealth And Products


By Johnny Rice, Benzinga Jacob Cohen, CEO of Mango Rx (NASDAQ: MGRX), was recently a guest on Benzinga’s All-Access. Mangoceuticals is focused on developing a variety of men's health and wellness products and services via a secure telemedicine platform. To date, the company has identified men's wellness telemedicine services and products as a growing sector especially related to the area of erectile dysfunction (ED), hair growth, and hormone replacement therapies. Learn more here: Featured photo by Taylor Grote on Unsplash. Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders. This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 Company Website

July 25, 2024 09:05 AM Eastern Daylight Time

Video Image
Article thumbnail News Release

Emerging Telemedicine Leaders: Stocks Shaping Healthcare's Digital Future


The telemedicine market is not just growing; it's booming. Valued at USD 97.48 billion in 2022 and projected to surge to USD 430.72 billion by 2031, with a robust CAGR of 17.95%, telemedicine is revolutionizing healthcare delivery worldwide. This industry uses telecommunications technology to provide remote patient consultations, diagnostics, and treatment, effectively bridging geographical barriers and lowering healthcare costs. Investors are increasingly drawn to this dynamic and transformative segment as demand for telemedicine grows, owing to its proven benefits in terms of accessibility and efficiency. Now, let's explore four stocks poised to capitalize on the potential growth in telemedicine. Mangoceuticals, Inc. (NASDAQ: MGRX), also known as MangoRx, is a pioneering force in men’s health and wellness, leveraging a secure telemedicine platform to offer a diverse array of products. The company's focus spans from hair growth solutions to hormone replacement therapies, with recent strides into the nutraceutical market marking a transformative expansion. Highlighting its commitment to innovation, MangoRx recently acquired a global patent portfolio aimed at preventing infections such as the common cold and HPV. This strategic move underscores MangoRx's pivot towards non-prescription, nutraceutical-based products featuring proprietary ingredients like GALALCOOL and zinc protoporphyrin IX. These components synergistically combat oral and respiratory infections, showcasing MangoRx’s dedication to preventive healthcare solutions. Financially, MangoRx reported a remarkable 108% revenue growth in the first quarter of 2024, reaching $214,000 compared to $100,000 in the same period last year. This substantial increase reflects successful customer acquisition strategies and early market penetration initiatives. Notably, the introduction of a direct-to-clinic sales division has further solidified recurring revenue streams by enabling healthcare professionals to prescribe MangoRx products directly. Securing DEA authorization for its HIPAA-compliant telemedicine platform through Surescripts marks a significant regulatory milestone for MGRX. This authorization allows the company to expand its product offerings to include controlled medications such as hormone replacement therapies, positioning MGRX at the forefront of telemedicine innovation. Amanda Hammer, COO of MangoRx, emphasized the transformative impact of this milestone, stating, “This authorization through Surescripts propels MangoRx into a new phase of growth, empowering us to introduce innovative products while maintaining rigorous regulatory compliance.” Internationally, MGRX has forged a strategic partnership with the International Society of Frontier Life Sciences and Technology (ISFLST), aimed at distributing its products in key markets including China, the Asia Pacific region, and Latin America (excluding Mexico). This collaboration leverages ISFLST’s extensive network to introduce MangoRx’s advanced health solutions to burgeoning markets, aligning with the company’s global expansion strategy. Innovation remains a cornerstone of MGRX's approach, highlighted by the initiation of efficacy studies on its patented respiratory illness prevention technology. These studies, announced on July 24, are conducted in collaboration with Vipragen Biosciences and IntraMont Technologies, Inc. They aim to validate the technology’s ability to prevent various viral infections, including H1N1 variants, Avian Flu, the common cold, and Coronavirus. James Intrator, CEO of IntraMont Technologies, expressed confidence in the technology’s potential, highlighting its unique mechanism of binding to viral proteins and acting as a barrier against respiratory viruses. The composition being tested contains a select tannin (enhanced polyphenol) and zinc gluconate. Previous research at Moscow State University showed a 93% decrease in active virus compared to the control group. The product is anticipated to be available as a lozenge or toothpaste, targeting the global influenza market valued at $8.28 billion in 2023. Mangoceuticals, Inc. (NASDAQ: MGRX) continues to lead in men’s health and wellness through strategic acquisitions, innovative product development, and expansive international outreach. Jacob Cohen, co-founder and CEO of MangoRx, reiterated the company’s mission, stating, “We are dedicated to advancing global health through innovative solutions. Our ongoing efforts in research, strategic partnerships, and product diversification position MangoRx to address critical healthcare needs worldwide.” Hims & Hers Health, Inc. (NYSE: HIMS) is a leading health and wellness platform committed to helping individuals feel great through better health. The company believes that how you feel in your body and mind transforms how you show up in life, driving its mission to build a future where nothing stands in the way of harnessing this power. By normalizing health and wellness challenges and innovating solutions, Hims & Hers makes feeling happy and healthy accessible. The company offers personalized care designed for effective results, acknowledging that no two people are the same. HIMS shares have shown remarkable growth potential, with shares up 150% year to date. This impressive performance positions Hims & Hers as an attractive option for investors, thanks to its rapid expansion, vast addressable market, and reasonable valuation. In the first quarter, the company reported a 46% year-over-year revenue increase, reaching $278.2 million. This growth was driven by a 41% increase in subscribers. With an impressive gross margin of 82%, Hims & Hers has the financial leeway to invest significantly in marketing, spending $130.6 million in the latest period. The company's long-term growth is supported by its early mover advantage, which allows it to capitalize on economies of scale and potential network effects by monetizing anonymized user data. In May, Hims & Hers launched a compounded GLP-1 weight loss injection at $199 per month, which is 85% less than brand-name versions like Ozempic and Wegovy sold by Novo Nordisk. Hims & Hers recently strengthened its leadership by appointing Kare Schultz to its Board of Directors. Schultz brings decades of leadership experience in the healthcare and pharmaceutical industries from organizations like Teva Pharmaceutical Industries, Lundbeck, and Novo Nordisk. His experience is expected to be invaluable, as Hims & Hers aims to redefine health and wellness for its customers. Andrew Dudum, CEO and co-founder of HIMS, expressed excitement about Schultz joining the board, stating, "We are in a transformative moment for healthcare with the opportunity to make life-changing treatments accessible to all who need them. Kare's experience gives us an incredible wealth of expertise." Schultz also shared his enthusiasm, saying, "Hims & Hers is on a trajectory to upend the healthcare industry. In my long career, this is the first company I have seen leveraging modern tools to break down barriers and change the status quo." With a combination of rapid growth, strategic leadership appointments, and innovative product offerings, Hims & Hers is certainly a telehealth stock to watch this year. GoodRx Holdings Inc. (NASDAQ: GDRX) is the top prescription savings platform in the U.S., helping over 25 million consumers and 750,000 healthcare professionals each year. Since its inception in 2011, the company has facilitated nearly $75 billion in savings on medications. GoodRx offers affordable options for both generic and brand-name drugs at over 70,000 pharmacies nationwide and provides valuable healthcare information. Recently, analysts at TD Cowen reaffirmed their positive outlook on GRX by maintaining a buy rating and a $16.00 price target. This confidence follows GoodRx’s announcement of a new biosimilar to Humira, an anti-inflammatory drug. The biosimilar, produced by Boehringer Ingelheim, will be available exclusively on GoodRx’s platform at $550 per two-pack—a 92% discount compared to Humira’s list price. This strategic move enhances GoodRx’s platform, positioning it as a key player in affordable medication options. The discount on Humira, a top-selling prescription drug globally, is expected to attract more users to GoodRx, potentially boosting its revenue and market position. Analysts view this as a significant growth opportunity within GoodRx’s business model. In addition to the Humira biosimilar, GDRX has partnered with Boehringer Ingelheim to provide the low-cost Adalimumab-adbm, now available at over 70,000 pharmacies. The company's upcoming quarterly report is anticipated to show 9% year-over-year growth in Monthly Active Consumers (MACs), supporting a positive revenue trajectory. GDRX has also made strides by appointing tech veteran Simon Patterson to its Board of Directors and setting ambitious financial targets, including over $1 billion in revenue and an adjusted EBITDA margin of 35%+ by 2026. With ongoing initiatives and a robust market presence, GoodRx continues to enhance its value proposition and growth potential. Teladoc Health (NYSE: TDOC) is at the forefront of virtual care, committed to enhancing the healthcare experience through personalized and comprehensive virtual services. Leveraging over two decades of expertise, Teladoc Health aims to support individuals throughout their entire health journey with advanced technology and data-driven insights. Despite its leadership in whole-person virtual care, Teladoc Health has faced significant challenges this year. The stock has dropped 56% due to disappointing quarterly earnings and mixed guidance. For Q1 2024, the company reported a net loss of $81.9 million, or 49 cents per share, slightly worse than the anticipated 47-cent loss. Revenue for the quarter reached $646.13 million, up 2.7% from the previous year. However, the company is grappling with high marketing and operating costs. On a brighter note, Teladoc is expanding its virtual nursing program, a strategic move to address the national nurse shortage. Additionally, its apps, which focus on managing diabetes, hypertension, and weight loss, are making strides in improving health outcomes by integrating physical and mental health activities. Looking ahead, analysts are optimistic about Teladoc’s recovery, projecting a 73% upside with a target price of $16.28. The recent appointment of Chuck Divita as CEO brings renewed hope. With his extensive experience in the healthcare sector, Divita is expected to steer Teladoc toward realizing its growth potential. Teladoc Health will report its Q2 2024 results on July 31, 2024, after market close, with a conference call scheduled at 4:30 p.m. E.T. to discuss the outcomes. Disclaimers: RazorPitch Inc. "RazorPitch" is not operated by a licensed broker, a dealer, or a registered investment adviser. This content is for informational purposes only and is not intended to be investment advice. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled. RazorPitch has been retained and compensated by Cambridge Consulting to assist in the production and distribution of content related to MGRX. RazorPitch is responsible for the production and distribution of this content. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. This content is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice. Nothing contained in this article constitutes a solicitation, recommendation, endorsement, or offer by RazorPitch or any third party service provider to buy or sell any securities or other financial instruments. All content in this article is information of a general nature and does not address the circumstances of any particular individual or entity. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. RazorPitch is not a fiduciary by virtue of any persons use of or access to this content. Contact Details Mark McKelvie +1 585-301-7700

July 25, 2024 06:00 AM Eastern Daylight Time

Article thumbnail News Release

The Fastest Growing Entertainment Concept In The World Opens Today In Roseville, Minnesota!


Activate, the world’s first active gaming facility, and TikTok viral sensation, is thrilled to have opened its doors in Roseville, Minnesota today. Riding high on the wave of success from its openings in Chicago, New Jersey, Atlanta, Dallas, and Kansas City, Activate delivers an unparalleled entertainment experience that captivates gamers' imaginations everywhere. Activate Roseville, MN is located at 1955 County Road B2 W, Unit 10, Roseville, MN 55113, United States. Activate is reshaping the gaming frontier, spanning 12 sites across the United States and 14 across Canada, with its momentum only gaining. With a global community of over 2.6 million players, and a massive global social media following, this immersive experience merges state-of-the-art technology with heart-pounding challenges, delivering an adventure fueled by adrenaline. “Launching our interactive and immersive gaming universe in Roseville marks a pivotal moment as we step into the Minnesota market," said Adam Schmidt, Founder & CEO of Activate. "We're thrilled to invite locals into our world of high-octane, tech-infused adventures that seamlessly blend physical prowess with digital thrills. This debut signals our entry into a vibrant new arena, reaffirming our dedication to crafting unforgettable journeys.” With over 9,750 square feet of fun, Activate Roseville’s new state-of-the-art gaming facility welcomes all skill levels, encouraging players to explore and create their unique experiences. Through progress tracking via Activate’s high-tech electronic RFID wristbands, players can rack up points, level up, and earn prizes along the way. Here’s what to expect: Each game lasts 1-3 minutes, 10 different game rooms to conquer; with the full gaming experience lasting 75 minutes. Top gaming rooms include the TikTok viral sensation Mega Grid with 500+ multi-activated rainbow-colored tiles, blasting the beaming bullseye in a game called Strike, and feeling like a modern-day spy in the Laser room Wear activewear and indoor runners. When: Mon-Thurs: Sun-Thurs 9:30 a.m. - 10:00 p.m., Fri-Sat 9:30 a.m. - 11:00 p.m. Where: 1955 County Road B2 W, Unit 10, Roseville, MN 55113, United States. Guests can sign up in groups of two to five players Additional Activate locations are set to open in 2024 across the United States in markets such as New York (Roosevelt Field), and Detroit, MI, along with internationally, including Dubai opening in the Fall, 2024 and launching in the UK in 2025. Activate operates over 30 locations across Canada, and the U.S. For a sneak peek into Activate’s dynamic gaming experience, click here. Join the Inner Circle to be the first to hear about new locations, behind-the-scenes information, deals, and more. Please find imagery assets here. Activate is the world’s first active gaming experience where players #EnterTheGame. Activate offers a unique blend of physical activity and gaming that promotes a healthy lifestyle. Each Activate location provides fun and interactive rooms for players to compete, earn stars and track achievements. With the global headquarters located in Winnipeg, Canada, Activate has grown to 30 locations across Canada, the U.S. and now the world! To join the active gaming movement, visit Follow Activate on social media: Facebook: Activate Instagram: @activategames TikTok: @activategames Contact Details Jalila Singerff +1 613-614-6777 Company Website

July 24, 2024 09:06 AM Eastern Daylight Time

Article thumbnail News Release

Players Health Partners with RealResponse to Enhance Athlete Safety and Wellbeing Through Real-Time Reporting

Players Health

Players Health, the leading provider of athlete safety and insurance solutions, today announced a partnership with RealResponse, a powerful web-based platform where athletes can anonymously report improper conduct through confidential two-way dialogue. Together, the two industry leaders will implement an innovative reporting platform for over five million athletes, leagues, and organizations in the Players Health specialty youth sports insurance ecosystem. This collaboration will blend RealResponse’s multi-channel communication technology into Players Health's sports-centric insurance, education, training, and compliance offerings, empowering kids, parents, guardians, and coaches to share feedback, ask questions, and access resources anonymously and in real-time. The RealResponse platform has already proven effective in facilitating rapid communication across amateur athletics, offering real-time anonymous visibility into critical situations, allowing for timely support for mental health needs. “Everything we do is centered around creating the safest and most accessible environments for amateur athletes to play the sports they love. RealResponse’s integration into our growing community allows us to provide our clients with the protected and secure communication tools needed to achieve clarity when investigating incidents,” said Tyrre Burks, CEO & Founder of Players Health. “This partnership creates a crucial framework for our clients to manage risk effectively and act promptly on valuable feedback.” As part of this partnership, Players Health becomes a preferred insurance, health and safety provider for RealResponse, ensuring that youth sports organizations have access to comprehensive coverage alongside innovative reporting solutions. Conversely, RealResponse will serve as a preferred feedback and anonymous reporting platform for Players Health, reinforcing its commitment to athlete safety and proactive risk management. This strategic alignment will enhance the resources available to organizations, and help foster a culture of safety and accountability across the youth sports ecosystem. “Players Health and RealResponse are committed to empowering amateur sports and educational institutions with innovative technological solutions that resonate with today's youth,” said David Chadwick, Founder and CEO of RealResponse. “By utilizing preferred communication channels—such as text, QR codes and WhatsApp—we're taking significant strides to prevent abuse and misconduct. Our advanced, seamless auto-routing capabilities streamline administrative processes, making it easier for organizations to uphold safety standards while supporting Players Health’s expanding network of clients.” Learn more about the partnership here: Players Health is a sports technology company providing digital risk management services, reporting tools and insurance products to sports organizations to empower them to stay ahead of their ever-changing safety and compliance responsibilities. Working towards establishing the safest environment for athletes, Players Health views the health and safety of athletes as a priority in today's sports landscape. ABOUT REALRESPONSE RealResponse is committed to elevating all voices in sports. The RealResponse community includes more than two million athletes, coaches, administrators, and staff, across college and professional sports, governing bodies, youth organizations, and integrity units. Founded in 2015, RealResponse empowers organizations and individuals to operate confidently in the high-risk world of sports – with real-time, two-way anonymous communications, surveys, compliance support, and data. For more information, visit Contact Details Digital Sport by Hot Paper Lantern Jackson Gaskins Company Website

July 24, 2024 08:00 AM Eastern Daylight Time

Article thumbnail News Release

Heat Stroke and Heat-Related Illness Rapidly Rising as Global Temperatures Climb

Centre for Neuro Skills

The number of people exposed to extreme heat has grown exponentially due to climate change, according to the World Health Organization. The New York Times reported that June 2024 was the 13 th consecutive month to break the global heat record. In 2023, 32 million people across California, Texas and Nevada experienced the hottest summer ever recorded in the United States. Centre for Neuro Skills (CNS), a leading provider of traumatic and acquired brain injury rehabilitation services with seven locations in California and Texas, shares essential tips for heat stroke prevention. Taking proactive measures to avoid heat stroke can be the difference between life and death. To avoid heat stroke: Dress in lightweight, loose-fitting clothing Apply sunscreen to avoid sunburn and keep the body cool Drink plenty of water and avoid sugary or alcoholic drinks Limit time outside to when it is cooler or if you must go out when temperatures are high, rest often Avoid leaving children or animals in parked cars, even if the windows are cracked open Monitor loved ones who are at high risk for developing heat stroke Check local news for extreme heat alerts “Of all the heat-related illnesses, heat stroke is the most serious. Heat stroke occurs when the body is no longer able to regulate temperature and cool down,” said Dr. Gary Seale, Regional Director of Clinical Services at CNS. “Body temperatures can rise rapidly to 104 degrees or higher which can cause damage to organs, including the brain, and result in permanent disability. Heat stroke can cause brain swelling, seizures, and lead to chronic inflammation, all of which disrupt brain function.” Children under 4 years old, adults over 65 years old with illnesses or medications that prevent body temperature regulation and people that are clinically classified as obese are all at higher risk of heat stroke. Heat exhaustion can be caused by engaging in strenuous activity, overexposure to hot weather and humidity and wearing excessive clothing that does not allow sweat to evaporate. Symptoms of heat stroke include high body core temperature, flushed skin, dizziness, loss of consciousness for longer than a few seconds, rapid heart rate, difficulty breathing, muscle cramps, seizures, vomiting and diarrhea. If you or a loved one are showing signs of heat stroke, call 911 immediately or transport the person to the hospital. While waiting for help, keep the person in a cool environment, remove unnecessary clothing and apply ice packs or cool water to their skin. ### About Centre for Neuro Skills Centre for Neuro Skills (CNS) is an experienced and respected world leader that provides intensive rehabilitation and medical programs for those recovering from all types of brain injury. CNS covers a full spectrum of advanced acquired and traumatic brain injury rehabilitation care, from residential and assisted living programs to outpatient rehabilitation, day treatment and telehealth services. Founded by Dr. Mark Ashley in 1980, CNS has seven locations in California and Texas and has been recognized by the American Stroke Association for its work in stroke rehabilitation. For more information about Centre for Neuro Skills, visit:, Instagram, Facebook, X (formerly known as Twitter), LinkedIn, and YouTube. Media, please note: To request an interview with CNS leadership or clinical staff, please contact Robin Carr at 415.766.0927 or Contact Details Landis Communications Inc. Robin Carr +1 415-766-0927 Company Website

July 23, 2024 08:01 AM Pacific Daylight Time

Article thumbnail News Release

The Rising Importance Of Minor Cannabinoids In The Growing Edible Market


By Kyle Anthony, Benzinga With society’s growing acceptance of cannabis consumption, a segment that has risen in popularity is edibles, which are simply products containing cannabinoids that one can eat or drink. While edibles containing cannabinoid compounds, such as THC (tetrahydrocannabinol), which induces a euphoric feeling, or CBD (cannabidiol), which has therapeutic attributes, are familiar to many, edibles containing minor cannabinoids are gaining traction among consumers due to the compound’s unique properties and potential health benefits. As such, the minor cannabinoid-infused edibles market stands at the precipice of potentially remarkable growth, fueled by discernible shifts in consumer behavior. The 2023 Minor Cannabinoid Market Recently, BayMedica, a firm focused on producing and commercializing rare cannabinoids and a subsidiary of InMed Pharmaceuticals (NASDAQ: INM), released a report detailing the growth of the minor cannabinoid market in 2023. The report utilized data from Headset, the largest dataset in the cannabis industry. It focuses on the growth, competition and consumer habits associated with minor cannabinoid-infused edibles in ten regulated cannabis states, which represent 85 million of the 158 million people living in areas where recreational cannabis is legal. The edible market experienced a robust 5.4% revenue surge in 2023, totaling $2.097 billion for the year. This growth was driven partly by innovative developments with minor cannabinoids. Gummies, a subset of the edible product category, exhibited strong sales, while minor cannabinoid-infused edibles witnessed an impressive 47% year-over-year growth, with sales totaling $391 million for the year. While there was a slight decline (i.e., from $14.29 to $12.54) in the average edible item price, the increased demand by consumers, strong growth prospects of the category and reduced input production costs were factors that appealed to cannabinoid brands seeking to gain strategic positioning in the industry. Minor Cannabinoids Explained Minor cannabinoids are naturally occurring compounds found in cannabis plants, distinct from the more well-known cannabinoids like THC and CBD. While THC and CBD dominate in terms of quantity and research focus, minor cannabinoids are changing the cannabinoid landscape due to their holistic capabilities. Minor cannabinoids are found in much smaller quantities than their more abundant counterparts THC and CBD, and are relatively rare in the full spectrum of cannabinoids that are present in a fully mature cannabis plant. Some notable minor cannabinoids include: Cannabichromene (CBC): CBC is recognized as a "booster" for other cannabinoids and is known for its interaction with the body's natural endocannabinoid, anandamide (also known as the bliss molecule). CBC seems to prevent the reabsorption of anandamide, enabling this bliss molecule to remain in the bloodstream for a longer duration. Tetrahydrocannabivarin (THCV): THCV is non-psychoactive and has a chemical structure similar to THC but produces different effects. It may act as an appetite suppressant, making it of interest for weight loss and for reducing unwanted food cravings that are typical with adult-use cannabis products. Additionally, As a CB1 receptor neutral antagonist, it can stimulate focus and energy, opening it up to a wide range of potential applications as an ingredient in both topical and ingestible products. Cannabidivarin (CBDV): CBDV is similar to CBD in its lack of psychoactive effects. Possible use cases for this minor cannabinoid span from the promotion of brain health and immune health to gut health. Cannabinol (CBN): CBN is formed as THC degrades and is mildly psychoactive. It is known for its potential sedative effects, which could be useful for treating insomnia. Additionally, CBN may have antibacterial properties and could aid in pain relief​. All cannabinoids work with the endocannabinoid system (ECS), which was only discovered in the late 1980’s. Every human being has an endocannabinoid system, and every cell type in the body has cannabinoid receptors that work as lock and key, with the over 140 cannabinoids that are known to exist. The ECS regulates and controls many of the body’s most critical functions, and it has been hypothesized that ECS activity may have therapeutic potential in almost all diseases affecting humans. Some of the more powerful cannabinoids, sometimes known as minor or rare cannabinoids, are impractical to extract either because they are represented in such small quantities in the plant or because their separation from other cannabinoids is cost-prohibitive. However, advancements in biosynthesis and synthetic chemistry, such as those utilized by companies like BayMedica, LLC, enable the production of these cannabinoids at commercial scales, paving the way for new therapeutic applications​. Minor Cannabinoids Gaining Momentum In 2023, 24 of the top 50 selling edibles incorporated minor cannabinoids, reflecting a significant shift in market trends. The innovation underpinning this material adoption speaks to the commitment of leading edible brands that are identifying formulations that resonate with a growing and diverse consumer base. This strategic action helped brands counter price compression by establishing a premium price and propelled the growth of minor-infused edible revenue. As detailed in the report, brands incorporating minor cannabinoids in cannabis products strategically command a premium, boasting a 6.3% higher average item price than products with standard THC formulations. This pricing trend reflects market recognition and a willingness to pay more for products enriched with minor cannabinoids, providing an opportunity for differentiation in a crowded market. It also gives credence to the entourage effect, a theory that various cannabis compounds work together to create specific effects and benefits. Using this theory, combining minor cannabinoids with major cannabinoids like THC and CBD allows for more medicinal benefits upon consumption, like pain relief. Cannabis brands incorporating minor cannabinoids also enjoy a remarkable 73% higher average EQ (Equivalent) price compared to THC-only counterparts. The use of EQ pricing is essential for fair product comparison, considering factors like potency or weight and highlighting consumers' tangible willingness to pay more for the inclusion of minor cannabinoids. Finally, given the diverse nature of minor cannabinoids, the products have high customer value and appeal. Tapping into their therapeutic properties empowers consumers to experience various health and wellness benefits, fostering a healthier and more balanced lifestyle. Commercial Adoption Commercialization of minor cannabinoids via edibles has provided insight into which minors are resonating with consumers. As illustrated in the report, CBN has established and maintained sales leadership within the minor cannabinoid landscape. Given its potential sedative effects, it can be hypothesized that consumer demand is being driven by individuals using it as a sleep aid. While CBG continues to exhibit strong year-over-year sales, market analysts project a potential deceleration in the future. Projections suggest that CBG, once the minor cannabinoid leader, may make way for emerging cannabinoids to take the forefront. In contrast to prior years, both CBC and THCV exhibited strong sales in 2023. For CBC, as research on its potential benefits as a mood enhancer gains momentum, its popularity in consumer preferences is likely to fuel sustained growth in sales, positioning it as a key player in the evolving cannabis market. THCV witnessed a substantial 140% year-over-year growth. Its improved affordability due to production enhancement made by lead processors like BayMedica has made THCV more accessible in the edibles market. Furthermore, rising awareness of its physical energy and appetite-suppressing effects, especially when combined with THC variants, positions it as a key player in shaping the evolving landscape of cannabinoid-based products. The Path Forward The edibles market is witnessing a paradigm shift as consumers are redefining their priorities around cannabis consumption, moving away from smoking in favor of the targeted therapeutic effects and consistent experiences offered by edibles. This move means the cannabis product landscape will be transformed in the coming years; as such, edible brands will need to align with the evolving needs of consumers, steering the industry towards a future where minor cannabinoids in edibles take center stage in the pursuit of holistic well-being. As a stakeholder in this industry transformation, BayMedica continues to focus on scaling its operations and expanding its product offerings to meet the growing demand for high-quality cannabinoids in various applications that may be used by a growing customer base. Featured photo by Elsa Olofsson on Unsplash. Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders. This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 Company Website

July 19, 2024 08:30 AM Eastern Daylight Time

Article thumbnail News Release

Style by Magda Launches Brand New Website Featuring Expanded Interior Design Services and Lifestyle Blog

Rev Up Marketers

Style by Magda, a brand celebrated for its fusion of classic elegance and contemporary trends, is excited to announce the launch of its newly redesigned website, The updated site enhances user experience, spotlights Magda’s comprehensive interior design services, and features her popular blog covering fashion, beauty, travel, and interior design. A Fresh Digital Experience The new website represents a pivotal moment for Style by Magda, aiming to provide an engaging and user-friendly online environment. Visitors can easily navigate through the site to explore Magda’s diverse offerings and stay informed about the latest lifestyle trends. “I'm thrilled to unveil our brand new website, which aligns with our dedication to innovation and customer satisfaction,” said Magda Callery, Founder and Creative Director of Style by Magda. Expanded Interior Design Services The redesigned website prominently features an expanded section dedicated to interior design services. Potential clients can explore Magda’s range of offerings, including personalised consultations, project management, and bespoke solutions for both residential and commercial spaces. An interactive portfolio highlights previous projects, illustrating Magda’s unique ability to create stylish and functional environments. Magda’s Blog Magda’s blog has been a favourite among followers, and the new website enhances this experience. The blog covers a broad spectrum of topics including fashion, beauty, travel, and interior design, providing readers with expert advice, tips, and insights. Visitors can delve into articles about the latest fashion trends, travel destinations, beauty routines, and home decor ideas, all curated by Magda. Key Features of the New Website 1. Enhanced User Experience: The site boasts a sleek, modern design and improved navigation, ensuring a smooth browsing experience on both desktop and mobile devices. 2. Interactive Portfolio: The interior design section includes an interactive portfolio that showcases Magda’s work, offering inspiration and ideas for prospective clients. 3. Comprehensive Services: Detailed descriptions of interior design services, along with an easy-to-use contact form for consultation requests, simplify the process for clients to engage with Magda’s expertise. 4. Engaging Blog Content: The blog is regularly updated with articles that keep readers informed and inspired, featuring categories on fashion, beauty, travel, and interior design. 5. Secure Shopping Experience: For those looking to purchase Magda’s curated collections, the website offers a secure and convenient checkout process with multiple payment options. Commitment to Sustainability Style by Magda maintains a strong commitment to sustainability in both fashion and interior design. The website includes dedicated sections outlining the brand’s eco-friendly practices and ethical sourcing, encouraging customers to make conscious and responsible choices. Special Launch Promotions To celebrate the launch, Style by Magda is offering special promotions, including discounts on interior design consultations and selected products. New newsletter subscribers will also receive an exclusive welcome discount. About Style by Magda Founded by Magda Callery, Style by Magda combines timeless elegance with contemporary trends across fashion and interior design. Magda is renowned for her work at the Cross Keys in Newbury, from decorating the interior to transforming the beer garden with stunning upcycled cable reels. Explore the New Website Magda invites everyone to visit the newly redesigned website at to discover the expanded interior design services, enjoy engaging blog content, and shop the latest collections. Contact Details Style By Magda Magda Callery Company Website

July 18, 2024 09:36 AM Eastern Daylight Time

Article thumbnail News Release

Forum Health Breaks into Denver Market with Acquisition of Concierge Functional and Regenerative Medicine Practice

Forum Health

Forum Health, LLC, a nationwide network of integrative and functional medicine providers and a pioneer in personalized healthcare, is expanding into a leading wellness-focused city with its acquisition of RevolutionaryMD in Denver, CO. Learn more about RevolutionaryMD. Renowned for its proclivity for health and wellness and prestigious medical research institutions, Denver is the ideal setting for a clinic rooted in personalized, cutting-edge healthcare. Phil Hagerman, Forum Health CEO: “Dr. Grover’s development of his revolutionary functional, regenerative, and anti-aging medical center aligns perfectly with the Forum Health clinic model, making this expansion a natural fit. His thirty years of success and expertise in central Denver is invaluable as we expand to a new state, enhancing the practice’s availability and offerings for wellness-focused patients.” The founder of RevolutionaryMD center in Cherry Creek North, Fred Grover, Jr., MD, is a Board-Certified Family Physician with training and certifications in Integrative, Functional, and Anti-Aging Medicine. He brings a wealth of experience and expertise to Forum Health's expanding network. Fred Grover Jr., MD, RevolutionaryMD Founder: “I’m excited to join Forum Health and grow our services and availability to help patients find a proactive approach to healthcare. We embrace the future of medicine by offering a robust preventative care model to treat the root cause of chronic conditions.” In addition to traditional testing, RevolutionaryMD offers genomic panels, advanced cardiovascular and cancer screening, inflammatory, and nutritional testing. It also employs AI for precise, personalized recommendations, moving beyond the depersonalized, often suboptimal outcomes of standard allopathic medicine. RevolutionaryMD has pioneered the concierge approach of functional medicine, advancing personalized healthcare with the latest treatments in: Anti-Aging and Regenerative Medicine for Improved Healthspan and Lifespan Bioidentical Hormone Replacement Therapy and Restoration Sexual Health and Wellness Aesthetic Dermatology Mind and Body Balancing Through Brain Health Modalities Integrated Ketamine and Sound Therapy for Depression IV Therapy for Post-COVID Syndrome, Inflammation and Healthy Mitochondrial Function Dr. Grover's dedication to functional and integrative medicine is evident in his role as an assistant clinical professor at the University of Colorado, Denver, his Board Certifications in Anti-Aging and Integrative Holistic Medicine, and his authorship of "Spiritual Genomics" and "Awakening Gaia." About Forum Health, LLC Forum Health, LLC is a nationwide provider of personalized healthcare steeped in the powerful principles of functional and integrative medicine. Our providers take a root-cause approach to care exploring lifestyle, environment, and genetics to help each patient achieve their ultimate health goals. Members have access to advanced medical treatments and technology, with care plans informed by data analytics and collaborative relationships. For more, visit Contact Details Britt Wittelsberger +1 410-852-0738 Company Website

July 18, 2024 08:50 AM Eastern Daylight Time

12345 ... 370